Format

Send to:

Choose Destination
See comment in PubMed Commons below
Heart Fail Clin. 2009 Oct;5(4):463-70. doi: 10.1016/j.hfc.2009.04.011.

What we may expect from biomarkers in heart failure.

Author information

  • 1National Heart Foundation of New Zealand, New Zealand. mark.richards@cdhb.govt.nz

Abstract

A profusion of circulating candidate biomarkers in heart failure is currently being investigated. Although all will advance our insight into the pathophysiology of heart failure, their potential clinical utility will depend on satisfaction of three key criteria. Assays must be accessible, reliable, and affordable. Secondly, the marker must provide information about cardiac function and prognosis not otherwise available. Finally, measurement of the marker must demonstrably lead to improved management and better clinical outcomes. Despite many promising candidates requiring fuller investigation, currently, only the natriuretic peptides satisfy these requirements.

PMID:
19631172
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk